Cervical Cancer (Oncology) - Drugs in Development, 2021

October 2021 | 2171 pages | ID: CF3591D2EF54EN
Global Markets Direct

Abstracts

Cervical Cancer (Oncology) - Drugs in Development, 2021

SUMMARY

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.Cervical cancer occurs when abnormal cells on the cervix grow out of control. Most cervical cancer is caused by a virus called human papillomavirus, or HPV. Abnormal cervical cell changes rarely cause symptoms. Symptoms of cervical cancer may include abnormal vaginal bleeding, such as bleeding after sex (vaginal intercourse), bleeding after menopause, bleeding and spotting between periods, and having longer or heavier (menstrual) periods than usual. Treatment options include surgery, radiation therapy, chemotherapy or a combination of methods.

REPORT HIGHLIGHTS

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cervical Cancer - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Cervical Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Cervical Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cervical Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 9, 15, 117, 98, 2, 5, 66, 15 and 5 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 9, 4, 1, 14 and 5 molecules, respectively.

Cervical Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

SCOPE

• The pipeline guide provides a snapshot of the global therapeutic landscape of Cervical Cancer (Oncology).
• The pipeline guide reviews pipeline therapeutics for Cervical Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Cervical Cancer (Oncology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Cervical Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Cervical Cancer (Oncology)

REASONS TO BUY

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Cervical Cancer (Oncology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Cervical Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contents

Introduction
Cervical Cancer - Overview
Cervical Cancer - Therapeutics Development
Cervical Cancer - Therapeutics Assessment
Cervical Cancer - Companies Involved in Therapeutics Development
Cervical Cancer - Drug Profiles
Cervical Cancer - Dormant Projects
Cervical Cancer - Discontinued Products
Cervical Cancer - Product Development Milestones
Appendix

List Of Tables

LIST OF TABLES

Number of Products under Development for Cervical Cancer, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Cervical Cancer - Pipeline by Aadi Bioscience Inc, 2021
Cervical Cancer - Pipeline by AbbVie Inc, 2021
Cervical Cancer - Pipeline by Abion Inc, 2021
Cervical Cancer - Pipeline by Abivax SA, 2021
Cervical Cancer - Pipeline by Advaxis Inc, 2021
Cervical Cancer - Pipeline by Advenchen Laboratories LLC, 2021
Cervical Cancer - Pipeline by Adze Biotechnology Inc, 2021
Cervical Cancer - Pipeline by Aeterna Zentaris Inc, 2021
Cervical Cancer - Pipeline by Affimed GmbH, 2021
Cervical Cancer - Pipeline by Agenus Inc, 2021
Cervical Cancer - Pipeline by Akeso Inc, 2021
Cervical Cancer - Pipeline by Alligator Bioscience AB, 2021
Cervical Cancer - Pipeline by Almac Discovery Ltd, 2021
Cervical Cancer - Pipeline by Alphamab Oncology, 2021
Cervical Cancer - Pipeline by amcure GmbH, 2021
Cervical Cancer - Pipeline by Amgen Inc, 2021
Cervical Cancer - Pipeline by Andes Biotechnologies, 2021
Cervical Cancer - Pipeline by Anew Oncology Inc, 2021
Cervical Cancer - Pipeline by Anteris Technologies Ltd, 2021
Cervical Cancer - Pipeline by AntiCancer Inc, 2021
Cervical Cancer - Pipeline by Apimeds Inc, 2021
Cervical Cancer - Pipeline by Apollomics Inc, 2021
Cervical Cancer - Pipeline by Arcus Biosciences Inc, 2021
Cervical Cancer - Pipeline by Asana BioSciences LLC, 2021
Cervical Cancer - Pipeline by Ascenta Therapeutics Inc, 2021
Cervical Cancer - Pipeline by Astex Pharmaceuticals Inc, 2021
Cervical Cancer - Pipeline by AstraZeneca Plc, 2021
Cervical Cancer - Pipeline by Bayer AG, 2021
Cervical Cancer - Pipeline by BeiGene Ltd, 2021
Cervical Cancer - Pipeline by Beijing Kangleweishi Biotechnology Co Ltd, 2021
Cervical Cancer - Pipeline by Beijing Neoantigen Biotechnology Co Ltd, 2021
Cervical Cancer - Pipeline by Beijing Weiyuan Likang Biological Technology Co Ltd, 2021
Cervical Cancer - Pipeline by Bio-Thera Solutions Ltd, 2021
Cervical Cancer - Pipeline by BioAtla Inc, 2021
Cervical Cancer - Pipeline by Biocad, 2021
Cervical Cancer - Pipeline by Biocon Ltd, 2021
Cervical Cancer - Pipeline by BioIntegrator Ltd, 2021
Cervical Cancer - Pipeline by Bioleaders Corp, 2021
Cervical Cancer - Pipeline by Biomics Biotechnologies Co Ltd, 2021
Cervical Cancer - Pipeline by BioNTech SE, 2021
Cervical Cancer - Pipeline by Biotheus Inc, 2021
Cervical Cancer - Pipeline by BioVaxys Technology Corp, 2021
Cervical Cancer - Pipeline by Boehringer Ingelheim International GmbH, 2021
Cervical Cancer - Pipeline by Bristol-Myers Squibb Co, 2021
Cervical Cancer - Pipeline by Celleron Therapeutics Ltd, 2021
Cervical Cancer - Pipeline by Cellestia Biotech AG, 2021
Cervical Cancer - Pipeline by Cellid Co Ltd, 2021
Cervical Cancer - Pipeline by Centus Biotherapeutics Ltd, 2021
Cervical Cancer - Pipeline by Changchun Bcht Biotechnology Co Ltd, 2021
Cervical Cancer - Pipeline by Chengdu Institute of Biological Products Co Ltd, 2021
Cervical Cancer - Pipeline by Chia Tai Tianqing Pharmaceutical Group Co Ltd, 2021
Cervical Cancer - Pipeline by Mycenax Biotech Inc, 2021
Cervical Cancer - Pipeline by Nanocan Therapeutics Corp, 2021
Cervical Cancer - Pipeline by NanoMab Technology Ltd, 2021
Cervical Cancer - Pipeline by NantCell Inc, 2021
Cervical Cancer - Pipeline by NeoTX Therapeutics Ltd, 2021
Cervical Cancer - Pipeline by Netris Pharma SAS, 2021
Cervical Cancer - Pipeline by Newish Technology Beijing Co Ltd, 2021
Cervical Cancer - Pipeline by NGM Biopharmaceuticals Inc, 2021
Cervical Cancer - Pipeline by Novartis AG, 2021
Cervical Cancer - Pipeline by Noyan Pajouhan Biopharma, 2021
Cervical Cancer - Pipeline by Obsidian Therapeutics Inc, 2021
Cervical Cancer - Pipeline by Ocellaris Pharma Inc, 2021
Cervical Cancer - Pipeline by Ology Bioservices Inc, 2021
Cervical Cancer - Pipeline by Onconova Therapeutics Inc, 2021
Cervical Cancer - Pipeline by Ono Pharmaceutical Co Ltd, 2021
Cervical Cancer - Pipeline by Origincell Technology Group Co Ltd, 2021
Cervical Cancer - Pipeline by Oxford Vacmedix UK Ltd, 2021
Cervical Cancer - Pipeline by PDS Biotechnology Corp, 2021
Cervical Cancer - Pipeline by Pfizer Inc, 2021
Cervical Cancer - Pipeline by Pharma Mar SA, 2021
Cervical Cancer - Pipeline by PharmAbcine Inc, 2021
Cervical Cancer - Pipeline by Philogen SpA, 2021
Cervical Cancer - Pipeline by Phoenix Life Sciences International Ltd, 2021
Cervical Cancer - Pipeline by PI Therapeutics Ltd, 2021
Cervical Cancer - Pipeline by Pionyr Immunotherapeutics Inc, 2021
Cervical Cancer - Pipeline by Plexxikon Inc, 2021
Cervical Cancer - Pipeline by Plus Therapeutics Inc, 2021
Cervical Cancer - Pipeline by Potenza Therapeutics Inc, 2021
Cervical Cancer - Pipeline by Precigen Inc, 2021
Cervical Cancer - Pipeline by Prelude Therapeutics Inc, 2021
Cervical Cancer - Pipeline by Prestige BioPharma Ltd, 2021
Cervical Cancer - Pipeline by Privo Technologies Inc, 2021
Cervical Cancer - Pipeline by PsiOxus Therapeutics Ltd, 2021
Cervical Cancer - Pipeline by Puma Biotechnology Inc, 2021
Cervical Cancer - Pipeline by Qilu Pharmaceutical Co Ltd, 2021
Cervical Cancer - Pipeline by Quadriga BioSciences Inc, 2021
Cervical Cancer - Pipeline by RAPT Therapeutics Inc, 2021
Cervical Cancer - Pipeline by Wuhan Binhui Biotechnology Co Ltd, 2021
Cervical Cancer - Pipeline by Xencor Inc, 2021
Cervical Cancer - Pipeline by Xiamen Innovax Biotech Co Ltd, 2021
Cervical Cancer - Pipeline by Y-Biologics Inc, 2021
Cervical Cancer - Pipeline by Yantai Rongchang Pharmaceutical Co Ltd, 2021
Cervical Cancer - Pipeline by Zeria Pharmaceutical Co Ltd, 2021
Cervical Cancer - Pipeline by Zhejiang Yangshengtang Biotech Co Ltd, 2021
Cervical Cancer - Pipeline by Zymeworks Inc, 2021
Cervical Cancer - Dormant Projects, 2021
Cervical Cancer - Discontinued Products, 2021

List Of Figures

LIST OF FIGURES

Number of Products under Development for Cervical Cancer, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021